In pancreatic alpha cells, the existence and function of the insulin receptor has not yet been fully established. In this study, to confirm the expression of functional insulin receptors in pancreatic alpha cells, we performed: 1)insulin receptor binding assay, 2) Northern blot analysis and RT-PCR (reverse transcription-polymerase chain reaction) amplification of insulin receptor mRNA, 3) immunocytochemical staining, 4) biosynthetic labelling of insulin receptor protein using [35S]methionine, 5) analysis of insulinstimulated autophosphorylation of the insulin receptor in glucagon secreting cell lines, In-R1-G9 and c~TC clone 6 cells. Glucagon secretion decreased with the addition of insulin in both cells. The receptor binding studies using [12SI-Tyr-A14] insulin revealed that both cells possessed a significant number of insulin receptors (In-R1-G9: K 1 = 2.1 x 109 mol/1-1, K 2 = 6.2 x 107 mol/1-1, R 1 = 0.27 x 10 4, R 2 = 1.86 x 10 4 sites/cell; aTC clone 6: K s = 2.1 x 109 mol/1-1, K 2 = 7.3 x 107 mol/1-1, R 1 = 0.27 • 10 4, R2 = 1.95 x 10 4 sites/cell). Northern blot analysis as well as RT-PCR amplification showed the mRNA specific for insulin receptor in both cells. By immunocytochemical staining using anti-insulin receptor a-subunit antibody, positive immunostaining for insulin receptor was observed in both cells.
tients [1] [2] [3] [4] . According to these studies, negative regulation of glucagon secretion by insulin has been proposed as the reason. Most, if not all, actions of insulin, have been shown to be mediated by the insulin receptor through its tyrosine kinase [5, 6] . Therefore, to account for the negative regulation of glucagon secretion by insulin, the existence of insulin receptors on pancreatic alpha cells has been proposed and studied by several investigators. Patel [7] demonstrated using the electron microscope that autoradiographic grains associated with [125I]insulin were found on alpha cells in isolated rat islets after [12sI]insulin treatment. However, Van Schravendijk et al. [8] studied the existence of insulin receptors using the receptor binding assay technique, but did not demonstrate significant binding of insulin to purified pancreatic alpha cells. Thus, the existence of insulin receptors has not yet been demonstrated on either purified pancreatic alpha cells or clonal pancreatic alpha-cell lines.
In this report, to confirm the expression of functional insulin receptors on pancreatic alpha cells, we performed biochemical, immunocytochemical, and molecular biological methods with two independent established clonal pancreatic alpha-cell lines; In-R1-G9 [9] and aTC clone 6 (aTC-6) cells [10] . We clearly demonstrate here the expression of insulin receptor mRNA and protein, and autophosphorylation of the insulin receptor by insulin stimulation in these clonal cell lines. Our results suggest that insulin may modulate glucagon secretion by the pancreatic alpha cell through its cell surface insulin receptor.
Materials and methods

Materials.
N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulphonic acid (HEPES), 2-amino-2-(hydroxymethyl)-l,3-propanediol (Tris), 3-amino-9-ethylcalbazol (AEC), dimethylsulphoxide (DMSO), Triton X-100, polyoxyethylenesorbitan monolaurate (Tween 20), sodium pyrophosphate, phenylmethyl sulphonyl fluoride (PMSF), sodium orthovanadate, sodium fluoride, Bacitracin, dithiothreitol (DTT), porcine insulin and DNase (RNase-free) were obtained from Sigma (St Louis, Mo., USA). [ 
c~-32p]dCTR [35S]methionine, [~-32P]ATR
and [125I-Tyr-A14]insulin were supplied by NEN-Dupont (Wilmington, Del., USA). RPMI-1640 medium and Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco (Grand Island, N.Y., USA). Oligotex and ampli Taq DNA polymerase, nitrocellulose membrane, RNase inhibitor, Avian Moloney virus-reverse transcriptase, Gene Clean kit, and Sequenase version 2.0 DNA sequencing kit were purchased from Takara Shuzo (Kyoto, Japan), Schleicher & Schuell (Dassel, Germany), Promega (Madison, Wis., USA), Seikagaku Corporation (Tokyo, Japan), Bio 101 Incorporated (La Jolla, Calif., USA), and United States Biochemical Company (Cleveland, Ohio, USA), respectively. Anti-insulin receptor/3-subunit monoclonal antibody (Ab-3), anti-insulin receptor c~-subunit polyclonal antibody, anti-rabbit Ig horseradish peroxidase linked F (ab')2 fragment and Protein G-Sepharose 4B were from Oncogene Science (Manhasset, N.Y., USA), UBI (Lake Placid, N.Y., USA), Amersham Corporation (Arlington Heights, Ill., USA), Zymed Laboratories Incorporated (South San Francisco, Calif., USA), respectively. Lab-Tek chamber slide and Aquatex were purchased from Nunc Incorporated (Naperville, Ill., USA) and Merck (Frankfurt, Germany), respectively.
Cell culture. In-R1-G9 cells cloned from hamster insulinoma (In-Ill-R1) [9] (a gift from Takaki) were grown in RPMI-1640 medium supplemented with 5% fetal bovine serum (FBS), 100 rag/1 streptomycin and 75 mg/1 penicillin sulphate under 5 % CO2 and 95 % air at 37 ~ aTC-6 cells, subcloned from the c~TC-1 line derived from a transgenic mouse adenoma expressing the simian virus (SV) 40 large T-antigen under the control of rat preproglucagon promoter [10, 11] (a gift from Hamaguchi), were grown in DMEM with 25 mmol/1 glucose, 10 % FBS, 100 rag/1 streptomycin and 75 mg/1 penicillin sulphate under 5 % CO 2 and 95 % air at 37 ~ Effect of insulin on glucagon secretion. One million In-R1-G9 or aTC-6 cells were plated on 60-ram dishes and cultured over-423 night to obtain a cell monolayer. Culture media were switched from RPMI-1640 medium with 5 % FBS to RPMI-1640 medium with 0.5 % bovine serum albumin (BSA) for In-R1-G9 cells and from DMEM (25 mmol/1 glucose) with 10 % FBS to DMEM (25 retool/1 glucose) with 0.5 % BSA for c~TC-6 cells, respectively, at 1 h before the addition of insulin. After washing twice, cells were incubated for 2 h in each medium with or without various concentrations of porcine insulin. Then 1 • 10 6 In-R1-G9 and c~TC-6 cells were incubated in RPMI-1640 medium with 0.5 % BSA and DMEM (25 retool/1 glucose) with 0.5 % BSA, respectively, with or without 10 -8 mol/1 porcine insulin for 2, 6, 12 and 24 h. Culture media were kept frozen until glucagon assay.
Insulin receptor binding assay. In-R1-G9 or aTC-6 cells (1 • 105, respectively) were plated in 12-well culture dishes. They were washed twice with binding buffer (100mmol/1 HEPES pH 7.5 containing 120mmol/1 NaC1, 1.2mmol/1 MgSO4, 1 retool/1 EDTA, 15 mmol/1 sodium acetate, 10 mmol/1 glucose and 1% BSA) and incubated with [125I-Tyr-A14]insulin (30 pmol/1) and various concentrations of unlabelled insulin for 16 h at 4~ After incubation, cells were washed three times with 1 ml cold phosphate-buffered saline (PBS) and solubilized with 500 ~1 0.1 tool/1 NaOH for 15 min at 37~ The radioactivity of the cell lysates was then measured by gamma counter. The data from binding assays were analysed using displacement curves and Scatchard plots [12] , and affinity constants and binding sites were calculated by the method of Thakur et al. [13] using a computer program based on the two-site model proposed by Rosenthal [14] .
Northern blot analysis. Total RNAs were isolated from In-R1-G9 or c~TC-6 cells and hamster or mouse tissues (liver and kidney) using the guanidium thiocyanate-CsC1 technique [15] . Poly(A) + RNAs were then extracted from total RNAs by Oligotex, according to the manufacturer's instructions. Poly(A) + RNA (10 ~xg) from liver or kidney cells, or both cells, were denatured with formaldehyde, separated by 1.0 % agarose gel electrophoresis, and transferred to nitrocellulose membranes. Hybridization of the filters with [c~-32P]dCTP random-priming labelled human insulin receptor cDNA (4.4 kb) [16] was carried out in 50% formamide, 5xSSC (1 • SSC = 150 mmol/1 NaC1, 15 mmol/1 sodium citrate), 5 x Denhardt's solution (1 • Denhardt's solution = 0.02 % polyvinyl pyrrolidone, 0.02 % Ficoll, 0.02 % BSA), 50 mmol/1 sodium phosphate buffer pH 7.0, 0.1% sodium dodecyl sulphate (SDS) and 100 vg/ml salmon sperm DNA overnight at 42 ~ with specific activity of i x 10 6 cpm/ml. The filters were washed in 1 • SSC with 0.2 % SDS and 0.5 • SSC with 0.2 % SDS at 60 ~ for 30 min and subjected to autoradiography.
Reverse transcription-polymerase chain reaction (RT-PCR)
analysis. After treatment with DNase (RNase-free) at 37 ~ for 60 rain in DNase buffer (0.1 tool/1 sodium acetate, 5 mmol/ 1 MnCI2), 3 ~tg of total RNA from In-R1-G9 or aTC-6 cells and hamster or mouse tissues (liver, kidney, skeletal muscle and adipose tissue) was reverse-transcribed into cDNA with 50 pmol of Oligo(dT)lT, 20 retool/1 of dNTPs, 50 U of RNase inhibitor and 12.5 U of Avian Moloney virus-reverse transcriptase in reverse transcriptase buffer (50 mmol/1 Tris pH8.3, 50 mmol/1 KC1, 8 mmol/1 MgCI2, 5 mmol/1 DTT) at 42 ~ for 120 rain, heated to 98 ~ for 10 rain, and immediately chilled on ice. RT-PCR amplifications were carried out using one tenth of the total reverse transcription mixture, 100 pmol of each primer, 2.5 retool/1 of dNTPs and 2.5 U of Ampli Taq DNA polymerase [17, 18] in 100 ~tl of reaction mixture containing PCR buffer (10 mmol/1 Tris pH 8.3, 50 mmol/1 KC1, 1.5 mmol/1 MgC12, 0.001% gelatin) using a thermal cycle programmer (Model 300; Astec, Fukuoka, Japan) under conditions of denaturation at 94 ~ for i min, annealing at 60 ~ for i rain, and extension at 72 ~ for 2 min for 30 cycles. The primers used for PCR reactions were designed from the common sequences between human and mouse insulin receptor cDNA [sense primer: 5'-CATCAAGGGTGAGGCAGAGA-3' residues 3273-3292 of human insulin receptor [16] (3135-3154, registered in the GenBank/EMBL Data Bank with accession number M10051) and 3105-3124 of mouse insulin receptor [19] (registered in the GenBank/EMBL Data Bank with accession number J05149); antisense primer: 5'-TTGGCCTCATCTTGGGGTrG-3' residues 3963-3982 of human insulin receptor [16] (3825-3844 GenBank/EMBL Data Bank) and 3795-3814 of mouse insulin receptor [19] (GenBank/ EMBL Data Bank)]. After amplification, the PCR products were subjected to 1% agarose gel electrophoresis, and extracted using a Gene Clean kit. The purified fragments were subcloned into the pUC 19 plasmids and sequenced by the dideoxynucleotide chain termination method with a Sequenase version 2.0 DNA sequencing kit and [a-s2p]dCTP [20] .
Immunocytochemical staining. In-R1-G9 or aTC-6 cells grown on Lab-Tek chamber slide (4-well) were fixed for 10 min in 100 % acetone. After rinsing 3 x i min with PBS, coverslips were incubated in a blocking solution consisting of PBS with 1% BSA and 0.02 % non-immune goat serum. After a further rinse with PBS, the cells were incubated overnight at 4 ~ with a rabbit anti-insulin receptor a-subunit antibody diluted at 1 : 100. The slides were rinsed with PBS, incubated with a donkey anti-rabbit Ig horseradish peroxidase linked F (ab')2 fragment, and the reactions were developed using AEC solution (0.02 % AEC/DMSO, 0.0475 mol/1 acetate buffer pH 5.0 and 0.006 % H202) as a chromogen. After a final rinse with PBS, the sections were briefly counterstained with haematoxylin and mounted with Aquatex.
[3ss]Methionine labelling of insulin receptor protein. Subconfluent In-R1-G9 or ctTC-6 cells were suspended in methionine-free medium at 37 ~ for 1 h followed by incubation with [35S]methionine (50 9Ci/ml) at 37 ~ for 12 h [21] . After labelling, these cells were solubilized in lysis buffer (50 mmol/1 HEPES pH7.5 containing 150mmol/1 NaC1, 1% Triton X-100, 5 mmot/1 EDTA, 5 mmol/1 EGTA, 20 mmol/1 sodium pyrophosphate, 1 mmol/1 PMSF, i mmol/1 sodium orthovanadate, 20 mmol/1 sodium fluoride, i mg/ml Bacitracin), and sonicated. After centrifugation at 100,000 x g for 90 min at 4 ~ the supernatants were incubated with anti-insulin re~ ceptor antibody (Ab-3) or non-immune serum as a control for 2 h at 4 ~ Immunoprecipitations were performed by addition of 40 ~1 of protein G-Sepharose 4B. After 2 h of incubation at 4~ the suspensions were sedimented by centrifugation at 10,000xg for 5 min at 4~ The immunoprecipitates were solubilized in sample buffer (62.5 mmol/1 Tris-HC1 pH 6.8 containing 10 % glycerol, 5 % 2-mercaptoethanol, 2 % SDS and 0.01% bromophenol blue) and heated in a boiling water bath for 5 rain. Proteins were then separated by SDS PAGE (6 % polyacrylamide gel electrophoresis) and autoradiography was performed.
Autophosphorylation of insulin receptor. In-R1-G9 or c~TC-6 cells grown in a 100-mm dish were incubated with RPMI-1640 medium with 0.5 % BSA and DMEM (25 mmol/1 glucose) medium with 0.5 % BSA with or without 10 -6 Bacitracin), centrifuged at 500 x g for 5 min at 4 ~ suspended in hypotonic buffer, and sonicated. After centrifugation of sonicates at 30,000 x g for 5 min at 4 ~ the supernatants were further centrifuged at 200,000 x g for 20 min at 4 ~ Pellets were suspended in lysis buffer, sonicated, and then centrifuged at 200,000 • for 20 min at 4~ The supernatants were adsorbed to microtitre wells previously coated with anti-insulin receptor antibody (Ab-3). Adsorbed insulin receptors were incubated with reaction mixture (50 mmol/l HEPES pH 7.5 containing 150 mmol/1 NaC1, 0.1% Triton X-100, 5 retool/1 MgC12, 5 mmol/1 MnC12, and 10 btmol/1 [7-32p] ATP (10-15 ~tCi/nmol) with or without 10 -7 mol/1 insulin at 24~ for 10 rain [6] .
The reaction mixtures were solubilized in sample buffer and heated in a boiling water bath for 5 min and separated by SDS PAGE (6 % polyacrylamide gel electrophoresis). The autoradiography was then performed.
Assay and statistical analysis.
Glucagon immunoreactivity in culture media was measured using OAL 123; Daiichi Radioisotope Institute (Tokyo, Japan) [22] , the antibody specific for pancreatic glucagon.
Data are presented as mean + SEM. Statistical analysis was performed using the Student's t-test. Statistical significance was accepted with p-values less than 5 %.
Results
Effect of insulin on glucagon secretion in In-R1-G9 and aTC-6 cells.
To examine the effect of insulin on glucagon secretion in In-R1-G9 and aTC-6 cells, secreted glucagon was measured by radioimmunoassay after the addition of various concentrations of insulin into the culture media. As shown in Figure 1A 
Insulin binding to In-R1-G9 and aTC-6 cells.
To analyse the insulin receptor on the cell surface, insulin binding assay was performed in In-R1-G9 and ~TC-6 cells. The displacement curve of In-R1-G9 and c~TC-6 cells is shown in Figure 2A . The concentra- (Fig.2B ). Affinity constants for high affinity site (K 0 and low affinity site (K2) in In-R1-G9 ceils were 2.1 X 1 0 9 and 6.2 x 107 mol/1-1, respectively, and binding sites for high affinity site (R 0 and low affinity site (R2) were 0.27 x 104 and 1.86 x 104 sites/cell, respectively. In a T C -6 cells, K 1 and K 2 were 2 . 1 x 1 0 9 and 7.3 x 107 mol/1-1, respectively, and R 1 and R 2 were 0.27 • 104 and 1.95 x 104 sites/cell, respectively.
Expression of insulin receptor m R N A in In-R1-G9 and aTC-6 cells.
To detect the existence of insulin receptor m R N A in In-R1-G9 and a T C -6 cells, Northern blot analysis and R T -P C R analysis of insulin receptor m R N A were performed. In the N o r t h e r n blot analysis using the h u m a n insulin r e c e p t o r e D N A as a probe, two major bands of insulin r e c e p t o r m R N A (9.6-and 7.4-kilobase (kb)), were detected in b o t h cells, as well as in hamster or mouse liver and kidney (Fig. 3) .
In R T -P C R analysis, a predicted size (710 basepair (bp)) D N A f r a g m e n t was amplified in b o t h cells (Fig.4) . B y sequence analysis, this 710 bp fragment was shown to be identical to the insulin r e c e p t o r e D N A sequence (data not shown).
Expression of insulin receptor protein in In-R1-G9
and aTC-6 cells. To find the expression of insulin re- Fig.4. (A, B) Detection of insulin receptor mRNA by RT-PCR method in In-R1-G9 and c~TC-6 cells. Total RNAs were prepared from both cells and rodent tissues -(A) hamster liver, kidney, skeletal muscle, adipose tissue and In-R1-G9 cells, (B) mouse liver, kidney, skeletal muscle, adipose tissue and aTC-6 cells, and reverse-transcribed into cDNA using oligo dT primer. PCR amplifications were carried out with a pair of primers designed from insulin receptor gene cDNA, and PCR products were subjected to 1.0 % agarose gel electrophoresis. The anticipated size of a 710 bp DNA fragment is observed from both cells as well as hamster and mouse tissues As shown in Figure 5 , positive immunostaining for insulin receptors was observed in both cells by using an anti-insulin receptor c~-subunit antibody. Replacement of the primary antibody with non-immune rabbit IgG showed no immunostaining in both cells. Furthermore, preincubation with porcine insulin before incubating with anti-insulin receptor ~-subunit antibody resulted in the abolition of positive immunostaining in both cells.
[35S]Methionine labelling of partially purified insulin receptors in both cells is shown in Figure 6 . Two major bands of Mr 135,000 and M r 95,000 corresponding to the c~ and/3 subunit of the insulin receptor were observed in both In-R1-G9 and c~TC-6 cells. In addition, another major band (M r 210,000) which seemed to be a precursor of the insulin receptor was also recognized in In-R1-G9 cells.
Insulin-stimulated autophosphorylation of the insulin receptor fi-subunit in In-R1-G9 and aTC-6 cells. To ex-
amine the insulin-stimulated phosphorylation of the insulin receptor expressed in In-R1-G9 and aTC-6 cells, autophosphorylation reactions were performed using the partially purified insulin receptors prepared from both cells. A n M r 95,000 band corresponding to the phosphorylated/3-subunit of the insulin receptor was observed only in the presence of insulin (10 -7 tool/l) in In-R1-G9 and aTC-6 cells (Fig. 7) .
Fig.6. SDS-PAGE of [35S]methionine-labelled insulin recep-
tor subunits in In-R1-G9 and c~TC-6 cells. Lysates of the cells were immunoprecipitated with anti-insulin receptor antibody (Ab-3) (+) or control non-immune serum (-), separated by SDS-PAGE (6% polyacrylamide gel electrophoresis) and analysed by autoradiography. Molecular weight markers are indicated on the left. Two major bands of M r 135,000 and M r 95,000 corresponding to the c~ and/3 subunits of insulin receptor are observed in both cells, and a band of M r 210,000 corresponding to a precursor of the insulin receptor is recognized only in In-R1-G9 cells
Discussion
In previous experiments using isolated pancreatic alpha cells [7, 8] , no definite conclusion was reached regarding the existence of an insulin receptor on the alpha cells, probably due to the difficulty in obtaining a large enough number of isolated pancreatic alpha cells to detect the insulin receptor, or the contamina-
Insulin (--) (4') (--) ('1")
In-R1-G9 ~TC-6 In-R1-G9 and a T e -6 cells. In-R1-G9 and a T e -6 cells do secrete glucagon, and do not produce insulin at levels detectable by radioimmunoassay. Also, in these cell lines, glucagon secretion by the stimulation of arginine (10 -2 mol/1) and epinephrine (10 -6 tool/l) was increased, and the increment by the stimulation of arginine (10 -2 mol/1) was suppressed by additional insulin stimulation (data not shown). These results are consistent with previous reports on the effect of arginine or epinephrine on glucagon secretion in glucagon-secreting cell lines or isolated pancreatic alpha cells [9, 23, 24] . From these data, we confirm that the cell lines used in our experiments show characteristics of native islet alpha cells. Furthermore, the cell lines did not contain pancreatic delta cells; no detectable somatostatin m R N A and negative immunocytochemical staining for somatostatin were observed, as reported previously [10, 25] . These glucagon cell lines, therefore, allowed us to obtain material homogeneous and intact enough to study the regulation of glucagon secretion from pancreatic alpha cells.
We found the decrease in glucagon secretion caused by insulin treatment in the range of 10 -12 to 427 10 .6 tool/1. The concentrations of insulin released into the core capillaries of pancreatic islets have been reported to be in the range of 10 -9 to 10 -7 mol/1 [26] . Therefore, glucagon secretion from normal islet alpha cells in vivo is considered to be regulated by insulin at concentrations of more than 10 -9 mol/1. In our study, glucagon secretion decreased even at insulin concentrations under 10-9mol/1. Our results are concordant with those of Phillipe [27] and Takaki et al. [9] who studied the regulation of glucagon secretion by insulin in In-R1-G9 cells. It is not quite clear why these clonal alpha cells in vitro show high sensitivity to insulin compared with intra-islet alpha cells in vivo. Phillipe [27] suggested that the number and/ or the affinity of the insulin receptor on intra-islet alpha cells might decrease by chronic exposure to the high concentrations of insulin secreted from beta cells compared with clonal alpha cells. This might account for the difference in insulin sensitivity between clonal alpha cells and intra-islet alpha cells.
Analysis of the receptor binding assay showed the estimated number of insulin receptors to be approximately 2.0 • 104 receptors per cell for both In-R1-G9 and a T e -6 cells, which was comparable with that of rat adipocytes and human fibroblasts ( -5 x 104/cell and -1.3 x 104/cell, respectively) [28, 29] . However, these were lower than those reported for human adipocytes and higher than those of human erythrocytes [30, 31] . In a previous report, Van Schravendijk et al. [8] did not find a significant number of high-affinity insulin receptors in isolated pancreatic alpha cells (400 sites per cell), which were 50-to 500-fold lower than in classic insulin target cells. The difference between our results and theirs might result from the differences of cell species. Our Scatchard analysis also revealed that the affinity constants for the high affinity site (K1) and low affinity site (K2) in In-R1-G9 and a T e -6 cells (In-R1-G9: K 1 = 2.1 x 109 mol/1-1, K 2 = 6.2 x 10 7 mol/1-1; a T e clone 6: K 1 = 2.1 x 109 mol/1-1, K 2 = 7.3 • 107 mol/1-1, respectively), which were similar to those of fibroblasts or adipocytes (K 1 = 109-10 l~ mol/1-1, K 2 = 107-108 mol/1-1) [28] [29] [30] [31] . From these receptor binding assay results, it was presumed that insulin receptors of these cells could function like those of insulin target cells.
We found 9.6 and 7.4 kb mRNAs specific for the insulin receptor in both In-R1-G9 and aTC-6 cells. These mRNAs seemed to be identical with two predominant insulin receptor mRNAs found in rodent tissues (liver, kidney, brain and muscle) [32] . The presence of insulin receptor m R N A was also confirmed by RT-PCR methods using a pair of primers (the sense and anti-sense primers) complementary to the eDNA of the insulin receptor gene. As a result, as expected a size 710 bp D N A fragment was obtained from both clonal cells, and hamster and mouse tissues. Furthermore, we determined the nucleotide sequence of this 710 bp D N A fragment which was found to be identical to that of the insulin receptors and different from that of the IGF-1 receptors [33] . From these results, we deduced the existence of insulin receptor mRNA in In-R1-G9 and aTC-6 cells.
Insulin receptor protein in In-R1-G9 and aTC-6 cells was demonstrated both by immunocytochemical staining and by [35S]methionine labelling. By [35S]methionine labelling of insulin receptor protein, we found two major bands of M r 135,000 and M r 95,000 corresponding to the a and/3 subunit of the insulin receptor in both cells. In addition, a band of M r 210,000 was detected in In-R1-G9 cells but not in aTC-6 cells. This M r 210,000 protein is known to be a precursor of the insulin receptor subunits, which is partially expressed in the plasma membrane [21, 34] . The receptor precursor shows little binding to the insulin and its turnover rate is faster (the halflife: 7-9 h) compared with mature insulin receptor (the half-life: 9-12 h) [21, 34] . Cleavage of insulin proreceptor into a and/3 subunit is considered to be catalysed by the cellular endoprotease; furin [35, 36] . Yanagita et al. [37] reported that the expression of furin varied among the cell lines. Therefore, we presume that the difference of expression of this M r 210,000 subunit between In-R1-G9 cells and aTC-6 cells might be due to the difference in furin expression.
We showed insulin-stimulated phosphorylation of the insulin receptor fl-subunit expressed in In-R1-G9 and aTC-6 cells. The phosphorylation of the insulin receptor fl-subunit is known to be an important step for insulin-mediated signal transduction of insulin [5, 6] . Therefore, we conclude that the function of insulin receptors expressed in In-R1-G9 and aTC-6 cells is to mediate insulin signals into the cells.
It has been reported that not only insulin but also IGF-1 can decrease glucagon secretion from pancreatic alpha cells [38] , suggesting the existence of IGF-1 receptors on pancreatic alpha cells. Since insulin is also known to bind to IGF-1 receptors, we could not neglect the possible involvement of the IGF-1 receptors on insulin-induced suppression of glucagon secretion in these cells. Further studies are necessary to clarify the role of these two receptors on glucagon secretion.
The exact molecular mechanism of regulation of glucagon secretion by insulin has not yet been elucidated. It is conceivable that the suppression of glucagon secretion by insulin is caused by the inhibition of post-transcriptional process and/or the reduced biosynthesis of glucagon. Philippe [27, 39] reported that the glucagon gene expression was negatively regulated by insulin at the transcriptional level through an insulin-responsive DNA element of the glucagon gene promoter in In-R1-G9 cells. However, further studies including the insulin receptor signalling pathway are necessary to elucidate the exact molecular K. Kisanuki et al.: Expression of insulin receptor on alpha cells mechanism of negative glucagon secretion regulated by insulin.
In conclusion, our study showed that the significant numbers of insulin receptors were correctly synthesized and expressed on clonal pancreatic alpha cells, In-R1-G9 and c~TC-6 cells, and may regulate insulin-stimulated negative regulation of glucagon secretion of both cells. These findings suggest that the regulation of insulin on pancreatic alpha cells may be mediated by specific cell-surface insulin receptors.
